Glenmede Trust CO Na Wave Life Sciences Ltd. Transaction History
Glenmede Trust CO Na
- $19.1 Billion
- Q4 2024
A detailed history of Glenmede Trust CO Na transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Glenmede Trust CO Na holds 47,409 shares of WVE stock, worth $527,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,409
Previous 39,075
21.33%
Holding current value
$527,662
Previous $320,000
83.13%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$203 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$107 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$91.9 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$75 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$74.7 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $966M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...